SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and ct-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Candlestick & Bollinger Bands
News Feed
- Find the latest SELLAS Life Sciences Group, Inc (SLS) stock discussion in Yahoo Finance’s forum. Share your opinion and gain insight from other stock traders and investors. More
- SELLAS Life Sciences Group Inc. company facts, information and financial ratios from MarketWatch. More
- Shares of Sellas Life Sciences Group Inc. (SLS) surged nearly 50% on Wednesday morning after the.. Markets One News Page: Wednesday, 26 February 2020 More
- Phase 3 Galinpepimut-S (GPS) Acute Myeloid Leukemia (AML) Study Open for Enrollment and Patient Screening Underway - - Regulatory Fe… More
- Get breaking news and analysis on SELLAS Life Sciences Group, Inc. (SLS) stock, price quote and chart, trading and investing tools. More
©Copyright 2020
5Charts.com